Irisin Hormone Levels in Endometrial Hyperplasia

NCT02903797 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2016-09-16

No results posted yet for this study

Summary

The purpose of the study is to determine serum irisin hormone levels an its relation between endometrial hyperplasia

Conditions

  • Endometrial Hyperplasia

Sponsors & Collaborators

  • Kayseri Education and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Erdem SAHİN · Kayseri Training and Research Hospital

Eligibility

Min Age
35 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-01-31
Completion
2017-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02903797 on ClinicalTrials.gov